Scientists Discover Common Medications May Secretly Alter Your Gut for Years
Researchers found that many commonly prescribed drugs, not just antibiotics, were linked to long-lasting microbial changes that could…
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company,…
When pills change shapes and colors, confusion is a side effect
At the ripe old age of 73, I take six drugs — four prescription and two over-the-counter pills…
Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drug
Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost
Glucagon-like peptide-1 (GLP-1) medications are drugs used to treat type 2 diabetes and support weight loss. They mimic…
Pfizer (PFE) earnings Q1 2026
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
Rare skin condition patients gain access to newly approved drug
The first authorised treatment for a painful and incurable skin condition has been made available in Ireland, in…
UnitedHealth, Cigna, Humana earnings show insurers are recovering
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to…
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…